Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, tolerability, PK, and efficacy of GS-5745 (andecaliximab) in adults with moderate to severe active ulcerative colitis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GS-5745 (andecaliximab) (andecaliximab)

Snippet

Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED | Results posted: 2021-02-01